Hi-D Imaging 4TAVR vs Imbio PHA (4.0.0)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Hi-D Imaging AG
VS
by Imbio (a subsidiary of 4DMedical)

AI Verdict

Tool A, Hi-D Imaging 4TAVR, is designed for pre-procedural planning for Transcatheter Aortic Valve Replacement (TAVR), offering automated measurements for surgical decision-making. Tool B, Imbio PHA (4.0.0), focuses on analyzing CT pulmonary angiogram scans to assess right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. While both utilize AI for cardiac imaging analysis, their distinct clinical applications mean they address different needs within cardiology.

Choose Hi-D Imaging 4TAVR if…

Choose Hi-D Imaging 4TAVR if your primary need is fully automated, AI-powered pre-procedural planning for Transcatheter Aortic Valve Replacement (TAVR). This cloud-based solution is ideal for cardiologists seeking fast, reproducible case evaluations with automated measurements and 2D/3D reconstructed images to enhance decision-making and streamline TAVR workflows.

View Hi-D Imaging 4TAVR →

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if you require rapid, AI-powered analysis of CT pulmonary angiogram (CTPA) scans to assess right ventricular dilation. This tool is best suited for radiologists and pulmonologists needing automated measurements of cardiac structures, including RV/LV and PA/Ao ratios, to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.

View Imbio PHA (4.0.0) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Hi-D Imaging 4TAVR Imbio PHA (4.0.0)
Pricing Contact for pricing Unknown
Deployment Cloud (SaaS) Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).
FDA Status Cleared AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Hi-D Imaging 4TAVR Imbio PHA (4.0.0)
Name Hi-D Imaging 4TAVR Imbio PHA (4.0.0)
Description FDA 510(k) cleared, AI-powered, cloud-based software that provides fully automated measurements for pre-procedural Transcatheter Aortic Valve Replacement (TAVR) planning, enhancing decision-making and streamlining clinical workflows. FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.
Company Hi-D Imaging AG Imbio
Categories Cardiology AI, Surgical AI Cardiology AI, Radiology & Imaging AI
Specialties Cardiology, Cardiothoracic Surgery, Radiology Cardiology, Pulmonology, Radiology
Key Features AI-powered automated measurements for TAVR planning, Cloud-based SaaS platform, One-click solution for image upload and analysis, Fully automated segmentation, Automated centerline-based MPR planes, 2D and 3D reconstructed images and views, Provides clinically-relevant parameters, Fast and reproducible case evaluations Automated measurement of right and left ventricle diameters, Automated measurement of main pulmonary artery and aorta diameters, Calculates RV/LV and PA/Ao ratios, Utilizes artificial intelligence algorithms for anatomical identification and measurement, Generates annotated DICOM images, Provides summary reports in PDF format, Integrates with native DICOM tools and workflows, Rapid, fully-automated assessment (typically in minutes)

Videos

Demos, reviews, and walkthroughs featuring Hi-D Imaging 4TAVR and Imbio PHA (4.0.0).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Hi-D Imaging 4TAVR is designed for pre-procedural Transcatheter Aortic Valve Replacement (TAVR) planning, providing automated measurements to enhance decision-making and streamline clinical workflows. Imbio PHA (4.0.0) is intended for automatically measuring cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.
Hi-D Imaging 4TAVR provides fully automated measurements for TAVR planning, including automated segmentation, centerline-based MPR planes, and 2D and 3D reconstructed images and views with clinically-relevant parameters. Imbio PHA (4.0.0) automatically measures right and left ventricle diameters, main pulmonary artery and aorta diameters, calculates RV/LV and PA/Ao ratios, and generates annotated DICOM images and summary reports in PDF format.
Imbio PHA (4.0.0) is explicitly HIPAA compliant, with third-party certification by Compliancy Group, and offers a Business Associate Agreement (BAA). The provided information for Hi-D Imaging 4TAVR does not explicitly state its HIPAA compliance or if a BAA is available.
Hi-D Imaging 4TAVR offers a one-click solution for image upload and analysis. Imbio PHA (4.0.0) integrates with native DICOM tools and workflows and delivers annotated images and summary reports directly to the patient study in PACS.
AI Tool Finder
AI-powered search. Results may not be comprehensive.